# Sleep Quality, Cognitive Performance, and Computerized Cognitive Training

> **NCT06328140** · — · WITHDRAWN · sponsor: **George West Mental Health Foundation d/b/a Skyland Trail**

## Conditions studied

- Bipolar Disorder
- Major Depressive Disorder
- Psychosis

## Interventions

- **DRUG:** Lurasidone
- **DRUG:** FDA Approved antidepressant treatment

## Key facts

- **NCT ID:** NCT06328140
- **Lead sponsor:** George West Mental Health Foundation d/b/a Skyland Trail
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2024-04-15
- **Primary completion:** 2025-01-22
- **Final completion:** 2025-01-22
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** we were unable to recruit participants according to the original protocol specifications. The sponsor would not allow for a modification so the study was stopped.
- **Last updated:** 2025-05-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06328140

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06328140, "Sleep Quality, Cognitive Performance, and Computerized Cognitive Training". Retrieved via AI Analytics 2026-09-17 from https://api.ai-analytics.org/clinical/NCT06328140. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*